144 related articles for article (PubMed ID: 25533328)
1. Conceptual frameworks and key dimensions to support coverage decisions for vaccines.
González-Lorenzo M; Piatti A; Coppola L; Gramegna M; Demicheli V; Melegaro A; Tirani M; Parmelli E; Auxilia F; Moja L;
Vaccine; 2015 Feb; 33(9):1206-17. PubMed ID: 25533328
[TBL] [Abstract][Full Text] [Related]
2. Decision support in vaccination policies.
Piso B; Wild C
Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
[TBL] [Abstract][Full Text] [Related]
3. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
4. [Decisional framework for varicella vaccine: challenges in the face of opportunity].
González-Lorenzo M; Tirani M; Piatti A; Coppola L; Gramegna M; Ruggiero F; Auxilia F; Moja L
Recenti Prog Med; 2016 Feb; 107(2):84-107. PubMed ID: 26901584
[TBL] [Abstract][Full Text] [Related]
5. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
6. National decision-making on adopting new vaccines: a systematic review.
Burchett HE; Mounier-Jack S; Griffiths UK; Mills AJ
Health Policy Plan; 2012 May; 27 Suppl 2():ii62-76. PubMed ID: 21733989
[TBL] [Abstract][Full Text] [Related]
7. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
8. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
9. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Donadel M; Panero MS; Ametewee L; Shefer AM
Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
[TBL] [Abstract][Full Text] [Related]
10. Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.
Morgan RL; Kelley L; Guyatt GH; Johnson A; Lavis JN
J Clin Epidemiol; 2018 Feb; 94():143-150. PubMed ID: 28988959
[TBL] [Abstract][Full Text] [Related]
11. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.
Moberg J; Oxman AD; Rosenbaum S; Schünemann HJ; Guyatt G; Flottorp S; Glenton C; Lewin S; Morelli A; Rada G; Alonso-Coello P;
Health Res Policy Syst; 2018 May; 16(1):45. PubMed ID: 29843743
[TBL] [Abstract][Full Text] [Related]
12. Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews.
Banzi R; Moja L; Pistotti V; Facchini A; Liberati A
Health Res Policy Syst; 2011 Jun; 9():26. PubMed ID: 21702930
[TBL] [Abstract][Full Text] [Related]
13. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
[TBL] [Abstract][Full Text] [Related]
14. Comparison of NITAG policies and working processes in selected developed countries.
Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.
Dahm P; Oxman AD; Djulbegovic B; Guyatt GH; Murad MH; Amato L; Parmelli E; Davoli M; Morgan RL; Mustafa RA; Sultan S; Falck-Ytter Y; Akl EA; Schünemann HJ
J Clin Epidemiol; 2017 Jun; 86():129-139. PubMed ID: 28377194
[TBL] [Abstract][Full Text] [Related]
16. National Advisory Groups and their role in immunization policy-making processes in European countries.
Nohynek H; Wichmann O; D Ancona F;
Clin Microbiol Infect; 2013 Dec; 19(12):1096-105. PubMed ID: 23957860
[TBL] [Abstract][Full Text] [Related]
17. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
Angelis A; Kanavos P
Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
[TBL] [Abstract][Full Text] [Related]
18. The decision making process on new vaccines introduction in South Africa.
Ngcobo NJ; Cameron NA
Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
[TBL] [Abstract][Full Text] [Related]
19. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
20. The role of health economic analyses in vaccine decision making.
Black S
Vaccine; 2013 Dec; 31(51):6046-9. PubMed ID: 23968768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
